NPS PHARMACEUTICALS INC
NPSP
NPSP was delisted on the 20th of February, 2015.
1 hedge funds and large institutions have $17.8M invested in NPS PHARMACEUTICALS INC in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 209 closing their positions.
100% less capital invested
Capital invested by funds: $3.63B → $17.8M (-$3.61B)
100% less funds holding
Funds holding: 213 → 1 (-212)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 209
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$573M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$313M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$218M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$213M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$199M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MFS
201
MSI Financial Services
Springfield,
Massachusetts
| – | -$23K | -650 | Closed |
|
|
BRWA
202
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$14 | -400 | Closed |
|
|
SIA
203
Stancorp Investment Advisers
Portland,
Oregon
| – | -$13K | -373 | Closed |
|
204
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$12K | -326 | Closed |
|
|
BFEC
205
Benjamin F. Edwards & Company
St. Louis,
Missouri
| – | -$11K | -300 | Closed |
|
206
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$10K | -279 | Closed |
|
|
TDC
207
Thompson Davis & Co
Richmond,
Virginia
| – | -$10K | -277 | Closed |
|
|
TRCT
208
Tower Research Capital (TRC)
New York
| – | -$8K | -216 | Closed |
|
209
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$7K | -200 | Closed |
|
210
SEI Investments
Oaks,
Pennsylvania
| – | -$2K | -80 | Closed |
|
NPSP Hedge Fund Activity: Q1 2015 in Review
1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q1 2015, worth a combined $17.8M — down 100% from $3.63B a quarter earlier.
Sellers outnumbered buyers: 209 funds closed out of NPSP and 0 opened new positions — a net loss of 209 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $573M sold.
- 1 institutional investor held NPS PHARMACEUTICALS INC (NPSP) as of Q1 2015, down from 213 in Q4 2014.
- Funds reported $17.8M of NPS PHARMACEUTICALS INC stock for Q1 2015, down 100% quarter-over-quarter.
- 0 funds opened new NPS PHARMACEUTICALS INC positions in Q1 2015 and 209 closed out, a net change of -209 holders.
- The largest NPS PHARMACEUTICALS INC seller in Q1 2015 was Fidelity Investments, an estimated $573M sold.
Based on aggregated 13F filings for Q1 2015.